These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5453153)

  • 1. [Distribution and elimination of isoniazid-H3 in pulmonary tuberculosis patients].
    Bondarev IM; Vasil'ev NA; Cherednichenko LP
    Probl Tuberk; 1970; 48(3):65-9. PubMed ID: 5453153
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparative study of tubazid inactivation in patients with pulmonary tuberculosis with fractional and single daily doses].
    Vilenskaia RN; Grebennik LI; Adamovich VN
    Probl Tuberk; 1969; 47(3):43-9. PubMed ID: 5354635
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
    Zhang LX
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Dec; 4(6):349-51. PubMed ID: 7344873
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid inactivation status and the development of chronic tuberculosis.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(3):227-34. PubMed ID: 5195905
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inactivation of the HINA preparations and certain indicators of the detoxicating function of the liver in patients with pulmonary tuberculosis].
    Fitsaĭ AV
    Probl Tuberk; 1973; 51(6):83-4. PubMed ID: 4764137
    [No Abstract]   [Full Text] [Related]  

  • 7. [Isoniazid-H3 distribution in a tubercular focus in the wall of a pulmonary cavern in rats].
    Cherednichenko LP
    Probl Tuberk; 1969; 47(5):80-5. PubMed ID: 5367976
    [No Abstract]   [Full Text] [Related]  

  • 8. [Isoniazid--essential facts and recent advances].
    Zierski M; Rotermund C
    Prax Klin Pneumol; 1984 Jun; 38(6):201-16. PubMed ID: 6382240
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hematic concentrations of free isoniazid after rectal administration].
    Cassetti B; Pirolli T
    Ann Ist Carlo Forlanini; 1966; 26(4):508-13. PubMed ID: 5991602
    [No Abstract]   [Full Text] [Related]  

  • 10. [Decomposition of INH and cycloserin preparations in the body of patients with tuberculosis of the lungs].
    Smirnov GA
    Probl Tuberk; 1977 Aug; (8):63-6. PubMed ID: 905277
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indicators of INH inactivation determined using a biological method and its use in monitoring antitubercular treatment].
    Czaplińska-Jóźwiak E; Szymański A; Dutkiewicz J
    Pneumonol Pol; 1986 Dec; 54(12):535-40. PubMed ID: 3588330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetics of isoniazid in patients with pulmonary tuberculosis].
    Protsiuk RG; Petrenko VI
    Sov Med; 1985; (3):94-8. PubMed ID: 4023845
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of the inactivation of tubazid in the endobronchial method of treatment of destructive pulmonary tuberculosis].
    Kanevskaia SS; Rzhavskov IuV
    Probl Tuberk; 1967; 45(10):44-8. PubMed ID: 5617546
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the isoniazid inactivation in the therapy of pulmonary tuberculosis].
    Gol'dshteĭn VD; Ioffe RA; Ponomareva ES
    Probl Tuberk; 1970; 48(1):34-9. PubMed ID: 5425443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of patients with fibrous-cavernous pulmonary tuberculosis with thioacetazone and large doses of isoniazid].
    Utkin VV; Reĭderman IV; Khaĭmovich NA
    Probl Tuberk; 1968; 46(4):17-22. PubMed ID: 5670965
    [No Abstract]   [Full Text] [Related]  

  • 16. Isoniazid-induced acne and pellagra. Occurrence in slow inactivators of isoniazid.
    Cohen LK; George W; Smith R
    Arch Dermatol; 1974 Mar; 109(3):377-81. PubMed ID: 4273616
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the treatment of experimental chronic tuberculosis with steroid hormone as a stimulation therapy and the distribution of 14C-labeled isoniazid in the tuberculous mice].
    Taniai S
    Kekkaku; 1967 Apr; 42(4):111-8. PubMed ID: 6065157
    [No Abstract]   [Full Text] [Related]  

  • 18. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Cas Lek Cesk; 1984 Feb; 123(6):158-64. PubMed ID: 6697364
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
    Borisova MI; Stakhanov VA; Sharkova TI; Ivashchenko NA
    Probl Tuberk Bolezn Legk; 2003; (7):34-7. PubMed ID: 12939876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isoniazid metabolism and the indicators of bioelectric activity of the brain in patients with tuberculosis during treatment with increased doses of isoniazid].
    Vilenskaia RN; Chelnokova NV
    Probl Tuberk; 1976; 3():46-9. PubMed ID: 967856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.